Advertisement
Organisation › Details
Zoetis (Group)
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. *
Start | 2016-11-15 existent | |
Industry | animal health | |
Industry 2 | veterinary diagnostics | |
City | n. a. | |
Address record changed: 2023-07-07 | ||
Basic data | Employees | H: 10,001 to 50,00 (2022-12-31) |
Currency | USD | |
Annual sales | 8,100,000,000 (revenue, annual, consolidated (2022) 2022-12-31) | |
* Document for »About Section«: Numaferm GmbH. (7/6/23). "Press Release: Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides". | ||
Record changed: 2023-07-07 |
Advertisement
More documents for Zoetis (Group)
- [1] Adivo GmbH. (9/15/23). "Press Release: Adivo Joins Zoetis to Bring the Benefits of Species-specific Antibody Therapies to Pet Owners Worldwide". Puchheim & Munich....
- [2] Univercells S.A.. (6/25/18). "Press Release: Univercells Appoints Christian Borgniet as Chief Operating Officer". Brussels....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top